Thirty Years of Research on Met Receptor to Move a Biomarker from Bench to Bedside
Alessandro Furlan(Centre National de la Recherche Scientifique), David Tulasne(Centre National de la Recherche Scientifique)
Cited by 68
Related Papers
Exon 14 Deleted MET Receptor as a New Biomarker and Target in Cancers
|JNCI Journal of the National Cancer Institute|2016|121
Caspase-generated fragment of the Met receptor favors apoptosis via the intrinsic pathway independently of its tyrosine kinase activity
|Cell Death and Disease|2013|36